BARTS1
MCID: BRT052
MIFTS: 32

Bartter Syndrome, Type 1, Antenatal (BARTS1)

Categories: Fetal diseases, Genetic diseases, Metabolic diseases, Nephrological diseases, Rare diseases

Aliases & Classifications for Bartter Syndrome, Type 1, Antenatal

MalaCards integrated aliases for Bartter Syndrome, Type 1, Antenatal:

Name: Bartter Syndrome, Type 1, Antenatal 58 30 6
Hyperprostaglandin E Syndrome 1 58 12 54 76
Bartter Syndrome, Type 1 58 13 41
Barts1 58 12 76
Hypokalemic Alkalosis with Hypercalciuria Antenatal 1 54 76
Bartter Disease Type 1 12 15
Antley-Bixler Syndrome with Genital Anomalies and Disordered Steroidogenesis 74
Hypokalemic Alkalosis with Hypercalciuria 1, Antenatal 58
Hypokalemic Alkalosis with Hypercalciuria 1 Antenatal 12
Bartter Syndrome, Antenatal Type 1 74
Bartter Syndrome Type 1 Antenatal 12
Bartter Syndrome Antenatal Type 1 54
Antenatal Bartter Syndrome Type 1 54
Bartter Syndrome 1, Antenatal 76
Antenatal Bartter Syndrome 1 76
Bartter Syndrome Type 1 12
Abs1 76
Bs1 76

Characteristics:

OMIM:

58
Inheritance:
autosomal recessive

Miscellaneous:
genetic heterogeneity (see antenatal bartter syndrome type 2, )


HPO:

33
bartter syndrome, type 1, antenatal:
Inheritance heterogeneous autosomal recessive inheritance


Classifications:



Summaries for Bartter Syndrome, Type 1, Antenatal

OMIM : 58 Bartter syndrome refers to a group of disorders that are unified by autosomal recessive transmission of impaired salt reabsorption in the thick ascending loop of Henle with pronounced salt wasting, hypokalemic metabolic alkalosis, and hypercalciuria. Clinical disease results from defective renal reabsorption of sodium chloride in the thick ascending limb (TAL) of the Henle loop, where 30% of filtered salt is normally reabsorbed (Simon et al., 1997). Patients with antenatal forms of Bartter syndrome typically present with premature birth associated with polyhydramnios and low birth weight and may develop life-threatening dehydration in the neonatal period. Patients with classic Bartter syndrome (see BARTS3, 607364) present later in life and may be sporadically asymptomatic or mildly symptomatic (summary by Simon et al., 1996 and Fremont and Chan, 2012). For a discussion of genetic heterogeneity of Bartter syndrome, see 607364. (601678)

MalaCards based summary : Bartter Syndrome, Type 1, Antenatal, also known as hyperprostaglandin e syndrome 1, is related to antley-bixler syndrome with genital anomalies and disordered steroidogenesis and bartter syndrome, type 3, and has symptoms including seizures, constipation and fever. An important gene associated with Bartter Syndrome, Type 1, Antenatal is SLC12A1 (Solute Carrier Family 12 Member 1). Related phenotypes are hyperparathyroidism and osteopenia

Disease Ontology : 12 A Bartter disease that has material basis in homozygous or compound heterozygous mutation in the sodium-potassium-chloride cotransporter-2 gene (SLC12A1) on chromosome 15q21.

UniProtKB/Swiss-Prot : 76 Bartter syndrome 1, antenatal: A form of Bartter syndrome, an autosomal recessive disorder characterized by impaired salt reabsorption in the thick ascending loop of Henle with pronounced salt wasting, hypokalemic metabolic alkalosis, and varying degrees of hypercalciuria. BARTS1 is a life- threatening condition beginning in utero, with marked fetal polyuria that leads to polyhydramnios and premature delivery. Another hallmark is a marked hypercalciuria and, as a secondary consequence, the development of nephrocalcinosis and osteopenia.

Related Diseases for Bartter Syndrome, Type 1, Antenatal

Diseases in the Antenatal Bartter Syndrome family:

Bartter Syndrome, Type 2, Antenatal Bartter Syndrome, Type 5, Antenatal, Transient
Bartter Syndrome, Type 1, Antenatal

Diseases related to Bartter Syndrome, Type 1, Antenatal via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 antley-bixler syndrome with genital anomalies and disordered steroidogenesis 11.3
2 bartter syndrome, type 3 11.1
3 bartter syndrome, type 4b, neonatal, with sensorineural deafness 11.1
4 bartter disease 10.2
5 spindle cell hemangioma 10.2
6 diabetes insipidus, nephrogenic, autosomal 10.0
7 diabetes insipidus 10.0
8 antenatal bartter syndrome 9.2 LOC107984755 LOC107984758 SLC12A1

Graphical network of the top 20 diseases related to Bartter Syndrome, Type 1, Antenatal:



Diseases related to Bartter Syndrome, Type 1, Antenatal

Symptoms & Phenotypes for Bartter Syndrome, Type 1, Antenatal

Human phenotypes related to Bartter Syndrome, Type 1, Antenatal:

33 (show all 41)
# Description HPO Frequency HPO Source Accession
1 hyperparathyroidism 33 occasional (7.5%) HP:0000843
2 osteopenia 33 HP:0000938
3 intellectual disability 33 HP:0001249
4 seizures 33 HP:0001250
5 failure to thrive 33 HP:0001508
6 constipation 33 HP:0002019
7 global developmental delay 33 HP:0001263
8 short stature 33 HP:0004322
9 dehydration 33 HP:0001944
10 fever 33 HP:0001945
11 vomiting 33 HP:0002013
12 hypokalemia 33 HP:0002900
13 generalized muscle weakness 33 HP:0003324
14 hypercalciuria 33 HP:0002150
15 paresthesia 33 HP:0003401
16 tetany 33 HP:0001281
17 polyhydramnios 33 HP:0001561
18 nephrocalcinosis 33 HP:0000121
19 hyperaldosteronism 33 HP:0000859
20 hypercalcemia 33 HP:0003072
21 diarrhea 33 HP:0002014
22 chondrocalcinosis 33 HP:0000934
23 premature birth 33 HP:0001622
24 renal salt wasting 33 HP:0000127
25 increased circulating renin level 33 HP:0000848
26 small for gestational age 33 HP:0001518
27 hypomagnesemia 33 HP:0002917
28 fetal polyuria 33 HP:0001563
29 hyposthenuria 33 HP:0003158
30 increased urinary potassium 33 HP:0003081
31 hypokalemic metabolic alkalosis 33 HP:0001960
32 hyperprostaglandinuria 33 HP:0003527
33 polyuria 33 HP:0000103
34 hypochloremia 33 HP:0003113
35 low-to-normal blood pressure 33 HP:0002632
36 renal potassium wasting 33 HP:0000128
37 renal juxtaglomerular cell hypertrophy/hyperplasia 33 HP:0000111
38 hyperactive renin-angiotensin system 33 HP:0000841
39 increased serum prostaglandin e2 33 HP:0003566
40 muscle spasm 33 HP:0003394
41 hyperchloriduria 33 HP:0002914

Symptoms via clinical synopsis from OMIM:

58
Skeletal:
osteopenia
chondrocalcinosis

Growth Other:
failure to thrive

Growth Height:
short stature

Laboratory Abnormalities:
hypokalemia
hypercalciuria
hypercalcemia
hyposthenuria
increased urinary potassium
more
Prenatal Manifestations Amniotic Fluid:
polyhydramnios
fetal polyuria
increased chloride levels

Prenatal Manifestations Delivery:
premature delivery

Cardiovascular Vascular:
low-to-normal blood pressure

Neurologic Central Nervous System:
seizures
developmental delay
mental retardation
paresthesias

Abdomen Gastrointestinal:
constipation
vomiting
diarrhea

Metabolic Features:
dehydration
fever
hypokalemic metabolic alkalosis

Muscle Soft Tissue:
muscle cramps
tetany
generalized weakness

Genitourinary Kidneys:
nephrocalcinosis
renal salt wasting
polyuria
renal potassium wasting
renal juxtaglomerular cell hypertrophy/hyperplasia

Growth Weight:
low birth weight

Endocrine Features:
hyperactive renin-angiotensin system
increased plasma renin
increased plasma aldosterone
hyperparathyroidism (in some patients)

Clinical features from OMIM:

601678

UMLS symptoms related to Bartter Syndrome, Type 1, Antenatal:


seizures, constipation, fever, vomiting, diarrhea, weakness, muscle cramp, polyuria

Drugs & Therapeutics for Bartter Syndrome, Type 1, Antenatal

Search Clinical Trials , NIH Clinical Center for Bartter Syndrome, Type 1, Antenatal

Genetic Tests for Bartter Syndrome, Type 1, Antenatal

Genetic tests related to Bartter Syndrome, Type 1, Antenatal:

# Genetic test Affiliating Genes
1 Bartter Syndrome, Type 1, Antenatal 30 SLC12A1

Anatomical Context for Bartter Syndrome, Type 1, Antenatal

Publications for Bartter Syndrome, Type 1, Antenatal

Articles related to Bartter Syndrome, Type 1, Antenatal:

# Title Authors Year
1
Bartter Syndrome Type 1 Presenting as Nephrogenic Diabetes Insipidus. ( 29527380 )
2018
2
Genetic heterogeneity in patients with Bartter syndrome type 1. ( 28000888 )
2017
3
Novel SLC12A1 (NKCC2) mutations in two families with Bartter syndrome type 1. ( 17998760 )
2007

Variations for Bartter Syndrome, Type 1, Antenatal

UniProtKB/Swiss-Prot genetic disease variations for Bartter Syndrome, Type 1, Antenatal:

76
# Symbol AA change Variation ID SNP ID
1 SLC12A1 p.Val272Phe VAR_010223 rs137853158
2 SLC12A1 p.Asp648Asn VAR_010224 rs137853157

ClinVar genetic disease variations for Bartter Syndrome, Type 1, Antenatal:

6 (show all 30)
# Gene Variation Type Significance SNP ID Assembly Location
1 SLC12A1 NM_000338.2(SLC12A1): c.1942G> A (p.Asp648Asn) single nucleotide variant Pathogenic rs137853157 GRCh37 Chromosome 15, 48543967: 48543967
2 SLC12A1 NM_000338.2(SLC12A1): c.1942G> A (p.Asp648Asn) single nucleotide variant Pathogenic rs137853157 GRCh38 Chromosome 15, 48251770: 48251770
3 SLC12A1 NM_000338.2(SLC12A1): c.814G> T (p.Val272Phe) single nucleotide variant Pathogenic rs137853158 GRCh37 Chromosome 15, 48521475: 48521475
4 SLC12A1 NM_000338.2(SLC12A1): c.814G> T (p.Val272Phe) single nucleotide variant Pathogenic rs137853158 GRCh38 Chromosome 15, 48229278: 48229278
5 SLC12A1 NM_000338.2(SLC12A1): c.1875G> A (p.Trp625Ter) single nucleotide variant Pathogenic rs137853159 GRCh37 Chromosome 15, 48543900: 48543900
6 SLC12A1 NM_000338.2(SLC12A1): c.1875G> A (p.Trp625Ter) single nucleotide variant Pathogenic rs137853159 GRCh38 Chromosome 15, 48251703: 48251703
7 SLC12A1 NM_000338.2(SLC12A1): c.724+4A> G single nucleotide variant Pathogenic rs774515747 GRCh37 Chromosome 15, 48518772: 48518772
8 SLC12A1 NM_000338.2(SLC12A1): c.724+4A> G single nucleotide variant Pathogenic rs774515747 GRCh38 Chromosome 15, 48226575: 48226575
9 SLC12A1 NM_000338.2(SLC12A1): c.2095delG (p.Asp699Thrfs) deletion Pathogenic rs1057519608 GRCh37 Chromosome 15, 48551449: 48551449
10 SLC12A1 NM_000338.2(SLC12A1): c.2095delG (p.Asp699Thrfs) deletion Pathogenic rs1057519608 GRCh38 Chromosome 15, 48259252: 48259252
11 SLC12A1 NM_000338.2(SLC12A1): c.2873T> C (p.Val958Ala) single nucleotide variant Benign/Likely benign rs1552311 GRCh37 Chromosome 15, 48580713: 48580713
12 SLC12A1 NM_000338.2(SLC12A1): c.2873T> C (p.Val958Ala) single nucleotide variant Benign/Likely benign rs1552311 GRCh38 Chromosome 15, 48288516: 48288516
13 SLC12A1 NM_000338.2(SLC12A1): c.843G> C (p.Glu281Asp) single nucleotide variant Likely pathogenic rs886039870 GRCh38 Chromosome 15, 48229307: 48229307
14 SLC12A1 NM_000338.2(SLC12A1): c.843G> C (p.Glu281Asp) single nucleotide variant Likely pathogenic rs886039870 GRCh37 Chromosome 15, 48521504: 48521504
15 SLC12A1 NM_000338.2(SLC12A1): c.1163delT (p.Phe388Serfs) deletion Pathogenic/Likely pathogenic rs779588655 GRCh38 Chromosome 15, 48234952: 48234952
16 SLC12A1 NM_000338.2(SLC12A1): c.1163delT (p.Phe388Serfs) deletion Pathogenic/Likely pathogenic rs779588655 GRCh37 Chromosome 15, 48527149: 48527149
17 SLC12A1 NM_000338.2(SLC12A1): c.1137delC (p.Phe380Serfs) deletion Pathogenic rs1057520300 GRCh38 Chromosome 15, 48234926: 48234926
18 SLC12A1 NM_000338.2(SLC12A1): c.1137delC (p.Phe380Serfs) deletion Pathogenic rs1057520300 GRCh37 Chromosome 15, 48527123: 48527123
19 SLC12A1 NM_000338.2(SLC12A1): c.1883C> A (p.Ala628Asp) single nucleotide variant Pathogenic rs1057520301 GRCh38 Chromosome 15, 48251711: 48251711
20 SLC12A1 NM_000338.2(SLC12A1): c.1883C> A (p.Ala628Asp) single nucleotide variant Pathogenic rs1057520301 GRCh37 Chromosome 15, 48543908: 48543908
21 SLC12A1 NM_000338.2(SLC12A1): c.2787dupC (p.Thr931Asnfs) duplication Pathogenic rs1057520302 GRCh38 Chromosome 15, 48288430: 48288430
22 SLC12A1 NM_000338.2(SLC12A1): c.2787dupC (p.Thr931Asnfs) duplication Pathogenic rs1057520302 GRCh37 Chromosome 15, 48580627: 48580627
23 SLC12A1 NM_000338.2(SLC12A1): c.2498_2499delGA (p.Arg833Ilefs) deletion Pathogenic rs1057520303 GRCh38 Chromosome 15, 48285118: 48285119
24 SLC12A1 NM_000338.2(SLC12A1): c.2498_2499delGA (p.Arg833Ilefs) deletion Pathogenic rs1057520303 GRCh37 Chromosome 15, 48577315: 48577316
25 SLC12A1 NM_000338.2(SLC12A1): c.1833delT (p.Phe611Leufs) deletion Pathogenic rs1057520304 GRCh38 Chromosome 15, 48251661: 48251661
26 SLC12A1 NM_000338.2(SLC12A1): c.1833delT (p.Phe611Leufs) deletion Pathogenic rs1057520304 GRCh37 Chromosome 15, 48543858: 48543858
27 SLC12A1 NM_001184832.1(SLC12A1): c.668C> T (p.Thr223Met) single nucleotide variant Likely pathogenic rs377680472 GRCh37 Chromosome 15, 48519315: 48519315
28 SLC12A1 NM_001184832.1(SLC12A1): c.668C> T (p.Thr223Met) single nucleotide variant Likely pathogenic rs377680472 GRCh38 Chromosome 15, 48227118: 48227118
29 SLC12A1 NM_000338.2(SLC12A1): c.2834_2873+12del deletion Likely pathogenic GRCh38 Chromosome 15, 48288477: 48288528
30 SLC12A1 NM_000338.2(SLC12A1): c.2834_2873+12del deletion Likely pathogenic GRCh37 Chromosome 15, 48580674: 48580725

Expression for Bartter Syndrome, Type 1, Antenatal

Search GEO for disease gene expression data for Bartter Syndrome, Type 1, Antenatal.

Pathways for Bartter Syndrome, Type 1, Antenatal

GO Terms for Bartter Syndrome, Type 1, Antenatal

Sources for Bartter Syndrome, Type 1, Antenatal

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....